LSTA / Lisata Therapeutics, Inc. - Net Long/Short Value

Lisata Therapeutics, Inc.
US ˙ NasdaqCM ˙ US1280583022

LSTA / Lisata Therapeutics, Inc. - Net Long/Short Value
Denne side viser netto-lange/korte værdiansættelser for hver institutionel besiddelse, der er rapporteret via 13F- eller NPORT-ansøgninger. For at beregne netto lang/kort værdi tilføjer vi egenkapitalværdien til værdien af call-optionen og trækker put-optionsværdien fra. Fonde, der rapporterer korte lånte positioner, vil rapportere aktieværdier som negative. Lange nettopositioner vil have positive tal i kolonnen netto lange/korte, og korte nettopositioner vil have negative værdier i denne kolonne.
Ejer Egenkapitalværdi
($1000)
Opkaldsværdi
($1000)
Sæt værdi
($1000)
Netto Lang/Kort
($1000)
Founders Capital Management
SOL Capital Management CO
UBS Group AG
Renaissance Technologies Llc
Geode Capital Management, Llc
Bank Of America Corp /de/
Cheviot Value Management, LLC
Royal Bank Of Canada
Caitong International Asset Management Co., Ltd
BlackRock, Inc.
Susquehanna International Group, Llp
JBF Capital, Inc.
HighTower Advisors, LLC
PenderFund Capital Management Ltd.
Advisor Group Holdings, Inc.
Vanguard Fiduciary Trust Co
Vanguard Global Advisers, LLC
Tower Research Capital LLC (TRC)
Gts Securities Llc
Css Llc/il
Fortitude Family Office, LLC
Cerity Partners LLC
Vanguard Group Inc
SBI Securities Co., Ltd.
Northern Trust Corp
Virtu Financial LLC
Morgan Stanley
Vanguard Capital Management Llc
State Street Corp
Citadel Advisors Llc
Citigroup Inc
Deltec Asset Management Llc
Rangeley Capital, LLC
Connective Capital Management, LLC
International Assets Investment Management, Llc
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
DE:8NE 2,96 €
GB:0HS8 3,14 $
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista